[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 14, Issue 3 (9-2012) ::
2012, 14(3): 215-221 Back to browse issues page
Effects of Chromium Supplementation on Glycemic Control in Patients with Type 2 Diabetes
Seyed Peyman Payami , Sara Saffarian , Atefeh Hasanzadeh
Diabetes Research Center, Ahvaz Jundishapur University of medical Sciences , Peyman_Payami@ajums.ac.ir
Abstract:   (11713 Views)
Introduction: Although some studies show that Chromium picolinate supplementation can improve glycemic control in type 2, diabetic patients, information available in this regard is conflicting. The aim of this study is to determine the effect of chromium picolinate on glycemic control in subjects with type 2 diabetes. Materials and Methods: In this the randomized, double blind placebo controlled clinical trial, 40 patients with type 2 diabetes were investigated. They were divided into two groups (n=20 each), the randomized and placebo groups, the former receiving 200 microgram chromium as chromium picolinate (n=20) for 3 months. Body composition, lipid profile, and glycemic control were determined at baseline and at the end of study. Results: Subjects randomized to chromium picolinate, as compared to the placebo group, had a significant decrease in HbA1C (-41%, P=0.007vs. 0.12%, P = 0.054) and FBS levels (-22.05%, P = .001 vs. -1.35%, P= .859). There was no improvement in body composition and lipid profiles of subjects randomized to chromium picolinate, compared to controls. Conclusion: Results of this study suggest that chromium picolinate supplementation in subjects with type 2 diabetes can improve glucose control but it has no effect on body composition and lipid profiles.
Keywords: Diabetes type 2, Chromium Picolinate, HbA1C
Full-Text [PDF 267 kb]   (4653 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2011/06/26 | Accepted: 2012/03/4 | Published: 2012/09/15
Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Payami S P, Saffarian S, Hasanzadeh A. Effects of Chromium Supplementation on Glycemic Control in Patients with Type 2 Diabetes. Iranian Journal of Endocrinology and Metabolism 2012; 14 (3) :215-221
URL: http://ijem.sbmu.ac.ir/article-1-1178-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 14, Issue 3 (9-2012) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4652